NRC Health Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
NRC Health (NRC) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$1.10 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-03.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2017-03-03
- NRC Health valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2014 was -$1.10M.
- NRC Health valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2013 was -$14.00K, a 106.54% decline from fiscal 2012.
- NRC Health valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2012 was $214.00K.
- NRC Health valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2014-12-31 | -$1.10M 10-K · filed 2017-03-03 | $1.10M 10-K · filed 2015-03-04 |
| 2013-12-31 | -$14.00K 10-K · filed 2016-03-04 | $14.00K 10-K · filed 2014-03-04 |
| 2012-12-31 | $214.00K 10-K · filed 2015-03-04 | |
| 2011-12-31 | $0.00 10-K · filed 2014-03-04 | |
| 2010-12-31 | $2.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |